x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    Artificial Intelligence Redefining Patient’s Eligibility for Immunotherapy

    More Author(s)

    Watch Now: Dr. Gowhar Shafi at Indian Cancer Congress 2023

    Artificial Intelligence Redefining Patient Eligibility for Immunotherapy

    Hear from Dr. Gowhar Shafi as he presents at the 3rd Indian Cancer Congress 2023, exploring how AI is transforming patient selection for immunotherapy. In this talk, Dr. Shafi discusses how advanced AI-driven analysis is enabling more precise, personalized eligibility assessments—ensuring the right patients receive the right treatments at the right time.

    Related Articles

    1Cell.Ai
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.